DSIP
10mg · 2ml
SKU: dsip-10mg
Delta sleep-inducing peptide for sleep quality and circadian rhythm support.
Product Specifications
Strength
10mg
Volume / Qty
2ml
Form
Lyophilized Powder
Suggested Retail Price
$70.00
Dosing Guide
Recommended Dose
100-250 mcg
Route
Subcutaneous
Frequency
Nightly or as needed
Clinician Access Required
Sign in to view clinician pricing & place orders
DSIP is available exclusively to verified clinicians under IRB-approved research protocol PPRN-001-2025.
IRB-Approved Research Protocol
PPRN-001-2025 ·IRCM-2025-467
Approved December 3, 2025 · Principal Investigator: Dr. M. Scott Mortensen, MD, MPAS, MLT
Save up to 80% with the 10,000 Growth Bundle
DSIP is included in this clinic-tier package. Bundle includes higher volume in weight loss, mitochondrial health, longevity, and tissue repair with 1 free Tirz 15mg + 1 free Reta 15mg as a bonus.
Most popular
Also frequently ordered
What other clinicians put in the same cart.
Related Products
Semax 10mg
Semax is a synthetic heptapeptide that enhances dopaminergic and cholinergic brain systems while boosting BDNF and supporting neurogenesis, synaptic plasticity, and cerebral blood flow. It provides sustained cognitive performance enhancement and neuroprotection against oxidative stress without stimulant-like side effects.
View Details
NA Selank Amidate 30mg
N-Acetyl Selank Amidate for enhanced anxiolytic, nootropic, and immune-modulating effects.
View Details
Selank 10mg
Selank is a synthetic peptide derivative of the naturally occurring human tetrapeptide tuftsin, developed to provide anxiolytic and cognitive-enhancing effects without benzodiazepine-like side effects. It modulates brain chemistry by increasing GABA receptor expression and optimizing serotonin metabolism while boosting BDNF levels to support neural plasticity.
View Details
PT-141 10mg
PT-141 (bremelanotide) is a synthetic melanocortin receptor agonist derived from alpha-melanocyte-stimulating hormone that stimulates sexual arousal through central nervous system pathways. Unlike vascular-based treatments, it targets MC-4R and MC-1R receptors to address sexual desire disorders in both males and females.
View Details